Norges Bank’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-180,700
Closed -$1.17M 1979
2023
Q4
$1.17M Buy
180,700
+19,700
+12% +$127K ﹤0.01% 1845
2023
Q3
$1.52M Buy
+161,000
New +$1.94M ﹤0.01% 1854
2022
Q4
Sell
-234,800
Closed -$4.49M 2190
2022
Q3
$4.49M Sell
234,800
-34,600
-13% -$630K ﹤0.01% 1789
2022
Q2
$4.11M Buy
+269,400
New +$3.98M ﹤0.01% 1808
2021
Q4
Sell
-61,400
Closed -$1.32M 2310
2021
Q3
$1.32M Buy
61,400
+21,800
+55% +$526K ﹤0.01% 2113
2021
Q2
$1.02M Buy
+39,600
New +$846K ﹤0.01% 2114
2021
Q1
Sell
-197,000
Closed -$2.27M 2202
2020
Q4
$2.27M Buy
+197,000
New +$1.8M ﹤0.01% 1935

Other funds holding CDMO

Norges Bank's CDMO Position: Q1 2024 in Review

Norges Bank sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2024, closing a stake of 180,700 shares — an estimated $1.17M sold.

Norges Bank first reported a position in CDMO in Q4 2020 and held it in 7 quarters. The position peaked at $4.49M in Q3 2022. 166 funds tracked by Wall St. Rank hold CDMO as of Q1 2024.

  • Norges Bank reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Norges Bank sold 180,700 Avid Bioservices, Inc. Common Stock shares in Q1 2024, an estimated $1.17M.
  • Norges Bank first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Norges Bank's Avid Bioservices, Inc. Common Stock position peaked at $4.49M in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2024.

Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.